Janus Henderson Group plc 13D and 13G filings for Sarepta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:40 am Sale |
2024-09-30 | 13G | Sarepta Therapeutics, Inc. SRPT |
JANUS HENDERSON GROUP PLC JHG |
4,358,511 4.600% |
-987,274 (-18.47%) |
Filing |
| 2024-02-13 1:34 pm Sale |
2023-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
JANUS HENDERSON GROUP PLC JHG |
5,345,785 5.700% |
-682,231 (-11.32%) |
Filing |
| 2023-02-10 11:28 am Sale |
2022-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
JANUS HENDERSON GROUP PLC JHG |
6,028,016 6.900% |
-1,217,846 (-16.81%) |
Filing |
| 2022-02-11 12:13 pm Purchase |
2021-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
JANUS HENDERSON GROUP PLC JHG |
7,245,862 8.300% |
7,245,862 (New Position) |
Filing |